crown ether or cryptand,4 tetraalkylammonium fluoride,5 and
its analogs.6 Although tetraalkylammonium fluoride and its
analogs became very popular reagents, they still suffered from
low stability and difficult control of the quality of the reagent.7
These problems were improved significantly by the recent
discovery by DiMagno et al. of “truly anhydrous TBAF”
generated in situ from the nucleophilic aromatic substitution
reaction of hexafluorobenzene with tetrabutylammonium cya-
nide.8 As an alternative, a new medium for this reaction was
studied by Chi et al., who reported that alkali metal fluorides
in ionic liquids,9 t-BuOH,10 or combinations thereof11 are
excellent for nucleophilic fluorination. As illustrated, most
investigations on nucleophilic fluorination were directed toward
the development of more reactive fluoride ion sources, which
is occasionally complicated by the formation of undesired
elimination side products due to fluoride’s strongly basic
character. In this regard, considering the immensely enhanced
leaving group ability of triflates (ca. 10,000 times faster than
tosylate toward solvolysis)12 compared to halides, mesylates,
or tosylates, we investigated the reaction profile of triflates with
fluoride ion species that are less nucleophilic than tetrabuty-
lammonium fluoride (TBAF) to determine whether they are
reactive enough to give both good conversion and selectivity
for displacement over elimination.13
In the course of the process development of LC15-0133 (1,
Scheme 1),14 a potent DPP-IV inhibitor, we had to devise a
viable large-scale synthesis of a key intermediate, 4-fluoro-
proline derivative 2a.15 Earlier in the development, it was
prepared by the reaction of 3-hydroxyl-proline 3a with DAST
(Table 1, entry 1). However, its high cost and exothermic
character, particularly during quenching of excess reagent,
rendered its use impractical for a large-scale operation. As
alternatives to DAST, we tested various methods such as CsF
in t-BuOH10 (entries 3 and 4), acetone (entry 5), and acetonitrile
in the presence of polymer-supported ionic liquids16 (entry 2)
with either 4-triflyl- or 4-mesyl-prolines (3a and b). In most of
Nucleophilic Fluorination of Triflates by
Tetrabutylammonium Bifluoride
Kyu-Young Kim, Bong Chan Kim, Hee Bong Lee,* and
Hyunik Shin*
Chemical DeVelopment DiVision, LG Life Sciences, Ltd.,
R&D Park, 104-1 Moonji-dong, Yusung-gu,
Daejeon 305-380, Korea
hbonglee@lgls.com; hisin@lgls.com
ReceiVed July 18, 2008
Careful examination of nucleophilicity, basicity, and leaving
group ability led us to discover the nucleophilic fluorination
of triflates by weakly basic tetrabutylammonium bifluoride,
which provides excellent yields with minimal formation of
elimination-derived side products. Primary hydroxyl groups
as well as secondary hydroxyl groups in acyclic chains or
in five-membered rings are excellent substrates, whereas
benzylic and aldol-type secondary hydroxyl groups give poor
yields as a result of the instability of their triflates.
Although organofluorine compounds are rarely found in
nature,1 the frequency of incorporation of fluorine into phar-
maceuticals is increasing at an explosive rate.2 As the most
electronegative element, the inclusion of fluorine into a molecule
commonly alters its metabolic stability, the basicity of basic
groups when embedded within proximity, and occasionally its
affinity toward a target protein. It also induces delicate changes
in conformational behavior,3 which can result in dramatic
changes in physicochemical properties.
Among the many methods used for the introduction of
fluorine, nucleophilic substitution reactions of aliphatic halides
or sulfonates by fluoride ion is the most commonly used due to
its high functional group tolerance compared with other methods.
As a classical method, alkali metal fluoride was frequently used
as a nucleophilic partner toward halides or sulfonates, although
usually at high temperatures to overcome limited solubility and
lower reactivity. Later, a more reactive “naked fluoride”
generated by the action of PTC led to the development of KF-
(4) Liotta, C. L.; Harris, H. P. J. Am. Chem. Soc. 1974, 96, 2250. (b) Gokel,
G. W. In Crown Ethers and Cryptands; Royal Society of Chemistry: Cambridge,
1991.
(5) Landini, D.; Montanari, F.; Rolla, F. Synthesis 1974, 428. (b) Cox, D. P.;
Terpinsky, J.; Lawrynowicz, W. J. Org. Chem. 1984, 49, 3216.
(6) Pilcher, A. S.; Ammon, H. L.; Deshong, P. J. Am. Chem. Soc. 1995,
117, 5166.
(7) Albanese, D.; Landini, D.; Penso, M. J. Org. Chem. 1998, 63, 9587.
(8) (a) Sun, H.; DiMagno, S. G. J. Am. Chem. Soc. 2005, 127, 2050. (b)
Sun, H.; DiMagno, S. G. Chem. Commun. 2007, 528.
(9) Kim, D. W.; Song, C. E.; Chi, D. Y. J. Am. Chem. Soc. 2002, 124, 10278.
(10) Kim, D. W.; Ahn, D.-S.; Oh, Y.-H.; Lee, S.; Kil, H. S.; Oh, S. J.; Lee,
S. J.; Kim, J. S.; Ryu, J. S.; Moon, D. H.; Chi, D. Y. J. Am. Chem. Soc. 2006,
128, 16394.
(11) Shinde, S. S.; Lee, B. S.; Chi, D. Y. Org. Lett. 2008, 10, 733.
(12) Crossland, R. K.; Wells, W. E.; Shiner, V. J., Jr. J. Am. Chem. Soc.
1971, 93, 4217.
(13) Schwesinger, R.; Link, R.; Wenzl, P.; Kossek, S. Chem. Eur. J. 2006,
12, 438.
(14) Kim, B. C.; Kim, K.-Y.; Lee, H. B.; Shin, H. Org. Process Res. DeV.
(1) O′Hagan, D.; Schaffrath, C.; Cobb, S. L.; Hamilton, J. T. G.; Murphy,
C. D. Nature 2002, 416, 279.
(2) (a) Bo¨lm, H.-J.; Banner, D.; Bendels, S.; Kansy, M.; Kuhn, B.; Mu¨ller,
K.; Obst-Sander, U.; Stahl, M. ChemBioChem 2004, 5, 637. (b) Thayer, A. M.
Chem. Eng. News 2006, 84, 15.
(3) Shoulders, M. D.; Hodges, J. A.; Raines, R. T. J. Am. Chem. Soc. 2006,
128, 8112. (b) Nicolleti, M.; O′Hagan, D.; Slawin, A. M. Z. J. Am. Chem. Soc.
2005, 127, 482. (c) Hunter, L.; O′Hagan, D.; Slawin, A. M. Z. J. Am. Chem.
Soc. 2006, 128, 16422.
2008, 12, 626.
(15) (a) Demange, L.; Me´nez, A.; Dugave, C. Tetrahedron Lett. 1998, 39,
1169. (b) Giardina, G.; Dondio, G.; Grugni, M. Synlett 1995, 55. (c) Ishi, A.;
Kuriyama, K.; Sudu, K.; Ootsuda, T.; Yasumoto, M.; Inomiya, N.; Ueda, K.;
Tsuruta, H. Chem. Abstr. 2005, 144, 88557; JP 2006008534, 2006. (d) Chiba,
J.; Takayama, G.; Takashi, T.; Yokoyama, M.; Nakayama, A.; Baldwin, J. J.;
Mcdonald, E.; Moriarty, K. J.; Sarko, C. R.; Saionz, K. W.; Swanson, R.; Hussain,
Z.; Wong, A.; Machinaga, N. Bioorg. Med. Chem. 2006, 14, 2725.
(16) Kim, D. W.; Chi, D. Y. Angew. Chem., Int. Ed. 2004, 43, 483.
8106 J. Org. Chem. 2008, 73, 8106–8108
10.1021/jo8015659 CCC: $40.75 2008 American Chemical Society
Published on Web 09/23/2008